| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 07/31/2008 | WO2008091740A2 Polyelectrolyte precipitation and purification of antibodies |
| 07/31/2008 | WO2008090749A1 Agent for modification of sh group |
| 07/31/2008 | WO2008090217A1 Purification of fc-tact fusion proteins using the oilbody technology |
| 07/31/2008 | WO2008089690A1 Preparation process of recombinant human p43 protein |
| 07/31/2008 | WO2008065415A3 Protein precipitation using a tag |
| 07/31/2008 | WO2008051447A3 Human salty taste receptor and methods of modulating salty taste perception |
| 07/31/2008 | WO2007067979A3 Targeting vector-phospholipid conjugates |
| 07/31/2008 | WO2005019407A3 Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases |
| 07/31/2008 | US20080182979 Fractionation of protein containing mixtures |
| 07/31/2008 | US20080182971 1-pyreneacetic acid, 1-pyrenemethylamine, 5(6)-carboxyfluorescein, EDTA, cyclam tetraacetic acid, lauric acid, cholesterol, D-biotin, carboxymethyl- beta -cyclodextrin, cysteine to form a peptide derivative; expose peptide derivative to silicon precursor; patterned by ink jet printing |
| 07/31/2008 | US20080182786 Target protein is supported on carrier made from a clay mineral, and by adding this to cells it is possible to introduce the target protein into the cells; clay mineral is preferably a layered clay mineral such as montmorillonite, vermiculite, and illite |
| 07/31/2008 | US20080182781 Process for the Preparation of Peptides |
| 07/31/2008 | US20080182284 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes |
| 07/31/2008 | US20080182270 Combinatorial artificial receptors including peptide building blocks |
| 07/31/2008 | US20080181935 Base-treated, detergent-treated telopeptide collagen and a plurality of stem cells; kit for augmenting, bulking or replacing tissue of a mammal |
| 07/31/2008 | US20080181883 Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same |
| 07/31/2008 | US20080181834 Method for screening microcrystallizations for crystal formation |
| 07/31/2008 | CA2674213A1 Purification of fc-taci fusion proteins using the oilbody technology |
| 07/31/2008 | CA2673851A1 Polyelectrolyte precipitation and purification of proteins |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1948817A1 Cell-free in vitro transcription and translation of membrane proteins into tethered planar lipid layers |
| 07/30/2008 | EP1948677A1 Method for pre-fractionation of complex samples |
| 07/30/2008 | EP1948676A1 Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same |
| 07/30/2008 | EP1651665B1 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 07/30/2008 | EP1638989B1 Method and apparatus for continuous large-scale radiolabeling of proteins |
| 07/30/2008 | EP1575553A4 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1355920B1 Extractive purification of lipopeptide antibiotics |
| 07/30/2008 | EP1276759B1 Reductive alkylation process on glycopeptides |
| 07/30/2008 | EP1179537B1 Solid phase peptide synthesis method |
| 07/30/2008 | CN101233230A Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof |
| 07/30/2008 | CN101233152A Method and system for in vitro protein folding |
| 07/30/2008 | CN101230377A Method for preparing antioxidant collagen peptide by spent of ocean alkaline protease 894 hydrolyzed aquatic products processing |
| 07/30/2008 | CN101230090A Blood peptide X and derivative thereof as well as preparation method and use thereof |
| 07/30/2008 | CN101230089A Solid-phase synthesis of glycyl histidyl lycine |
| 07/30/2008 | CN101230088A Method for extracting native natural collagen from animal skin or/and tendon |
| 07/30/2008 | CN101230087A Technique for producing hirudin by using poecilobdella manillensis frozen fresh body as raw material |
| 07/30/2008 | CN101230086A Technique for producing hirudin by using poecilobdella manillensis saliva as raw material |
| 07/30/2008 | CN101230085A Method for preparing solid-phase synthesized carrier |
| 07/30/2008 | CN100406891C 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离 Identification of isolated compounds utilizing EPF receptor binding or regulate the activity and hDRR of hDRR |
| 07/30/2008 | CN100406470C Protein for causing sperm not wandering prepared from india worm lizard body cavity liquid |
| 07/30/2008 | CN100406434C Method for recycling astaxanthin and protein from waste water of chitin, chitosan production |
| 07/30/2008 | CN100406058C Placenta factor, preparation method and application |
| 07/29/2008 | US7405320 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 07/29/2008 | US7405273 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 07/29/2008 | US7405271 Alkaline protease |
| 07/29/2008 | US7405269 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 07/29/2008 | US7405267 Fermenting and isolating glycopeptide antibiotic using synthetic absorbent; bactericides |
| 07/29/2008 | US7405201 Antibacterial macrocycles |
| 07/29/2008 | US7405198 Glycopegylated erythropoietin |
| 07/29/2008 | US7405083 using mass spectrometry; sample well having hydrophobic surface treatment |
| 07/29/2008 | US7405058 Thymic stromal lymphopoietin (TSLP); nucleic acid encoding polypeptide of given sequence; use in peptide fragmentation studies and molecular weight measurements |
| 07/29/2008 | US7405051 Method of screening antiplatelet agents |
| 07/29/2008 | US7405048 Improving production by immunocompetent cells; side effect reduction |
| 07/29/2008 | US7405042 Method of extracting nucleic acid or protein using dendrimers and dendrimer-compositional substances |
| 07/29/2008 | US7404956 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | CA2405486C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2346825C Method for production of stroma-free hemoglobin |
| 07/29/2008 | CA2331337C Site specific protein modification by mutagenesis |
| 07/29/2008 | CA2273071C Method for ligating oligopeptides |
| 07/29/2008 | CA2223702C Therapeutic fragments of von willebrand factor |
| 07/29/2008 | CA2203033C Compounds and compositions for delivering active agents |
| 07/24/2008 | WO2008088837A2 Expression of hla proteins on non-human cells |
| 07/24/2008 | WO2008088200A1 Affinity separation by partition enhancing material conjugated biomolecules in aqueous two-phase extraction system |
| 07/24/2008 | WO2008087184A2 Process for the purification of fc-containing proteins |
| 07/24/2008 | WO2008086811A1 Production of biofuel and protein from a raw material |
| 07/24/2008 | WO2008086621A1 A method for commercial isolation of egg yolk igy, its product, and uses of the product |
| 07/24/2008 | WO2008064465B1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan |
| 07/24/2008 | WO2008030901A3 Biomarker fragments for the detection of human bnp |
| 07/24/2008 | WO2008020741A3 Method for extracting phospholipase a2 from agkistrodon blomhoffii venom |
| 07/24/2008 | WO2008020739A3 METHOD FOR EXTRACTING α-SPECIFIC TROMBIN-LIKE ENZYME (ANCISTRON-B) FROM AGKISTRODON BLOMHOFFII USSURIENSIS VENOM |
| 07/24/2008 | WO2006096207A3 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 07/24/2008 | WO2004071573A3 Hypoxia induced mitogenic factor |
| 07/24/2008 | US20080177521 Modeling of mPGES-1 three-dimensional structures: applications in drug design and discovery |
| 07/24/2008 | US20080177038 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 07/24/2008 | US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity |
| 07/24/2008 | US20080177035 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides |
| 07/24/2008 | US20080177033 Self-Assembly of Peptide-Amphiphile Nanofibers under Physiological Conditions |
| 07/24/2008 | US20080177032 Catalytically active peptides |
| 07/24/2008 | US20080177029 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
| 07/24/2008 | US20080176794 Long lasting fusion peptide inhibitors of viral infection |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176789 comprising subjecting the materials to sequential chromatography on an anion-exchange matrix and a hydrophobic interaction matrix such as material is phenyl sepharose, to produce blood-coagulation factor XIII polypeptides precipitates, used for preventing bleeding and treating blood disorders |
| 07/24/2008 | US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases |
| 07/24/2008 | US20080176288 Colony stimulating factor fusion protein comprising polyanionic polymer for use tool to enhance drug delivery |
| 07/24/2008 | CA2712375A1 A method for commercial isolation of egg yolk igy, its product, and uses of the product |
| 07/24/2008 | CA2676303A1 Production of biofuel and protein from a raw material |
| 07/24/2008 | CA2673771A1 Process for the purification of fc-containing proteins |
| 07/24/2008 | CA2673516A1 Method of purifying apolipoprotein a-1 |
| 07/24/2008 | CA2672091A1 Disintegrin variants and pharmaceutical uses thereof |
| 07/23/2008 | EP1947176A1 Method for stabilization of biological molecule and composition |
| 07/23/2008 | EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 07/23/2008 | EP1947111A1 Novel mucin glycoprotein and use thereof |
| 07/23/2008 | EP1946108A2 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 07/23/2008 | EP1945673A2 Targeting and tracing of antigens in living cells |
| 07/23/2008 | CN101228178A Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments |
| 07/23/2008 | CN101228126A Process for the preparation of crystalline perindopril |